In this study, we aimed to generate novel monoclonal antibodies (mAbs) to Omp25 and to develop new immunoassays for diagnosis of brucellosis or evaluation of therapeutic efficacy of brucellosis in clinical practice. The gene discussed is SYNJ2BP; the disease is brucellosis.